These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 16982747)

  • 1. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.
    Aghi M; Cohen KS; Klein RJ; Scadden DT; Chiocca EA
    Cancer Res; 2006 Sep; 66(18):9054-64. PubMed ID: 16982747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
    Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
    Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
    Kryczek I; Lange A; Mottram P; Alvarez X; Cheng P; Hogan M; Moons L; Wei S; Zou L; Machelon V; Emilie D; Terrassa M; Lackner A; Curiel TJ; Carmeliet P; Zou W
    Cancer Res; 2005 Jan; 65(2):465-72. PubMed ID: 15695388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis.
    Sbaa E; Dewever J; Martinive P; Bouzin C; Frérart F; Balligand JL; Dessy C; Feron O
    Circ Res; 2006 May; 98(9):1219-27. PubMed ID: 16601228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.
    Ceradini DJ; Kulkarni AR; Callaghan MJ; Tepper OM; Bastidas N; Kleinman ME; Capla JM; Galiano RD; Levine JP; Gurtner GC
    Nat Med; 2004 Aug; 10(8):858-64. PubMed ID: 15235597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P; Xu L; Pan S; Brekken RA; Yang ST; Whitaker GB; Nagane M; Thorpe PE; Rosenbaum JS; Su Huang HJ; Cavenee WK; Cheng SY
    Cancer Res; 2001 Dec; 61(23):8569-77. PubMed ID: 11731444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
    Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
    Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue.
    Ceradini DJ; Gurtner GC
    Trends Cardiovasc Med; 2005 Feb; 15(2):57-63. PubMed ID: 15885571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation.
    Zhang LN; Wilson DW; da Cunha V; Sullivan ME; Vergona R; Rutledge JC; Wang YX
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):765-72. PubMed ID: 16456092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
    Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flt-1 signaling in macrophages promotes glioma growth in vivo.
    Kerber M; Reiss Y; Wickersheim A; Jugold M; Kiessling F; Heil M; Tchaikovski V; Waltenberger J; Shibuya M; Plate KH; Machein MR
    Cancer Res; 2008 Sep; 68(18):7342-51. PubMed ID: 18794121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice.
    Dar A; Kollet O; Lapidot T
    Exp Hematol; 2006 Aug; 34(8):967-75. PubMed ID: 16863903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets and stromal cell-derived factor-1 in progenitor cell recruitment.
    Stellos K; Gawaz M
    Semin Thromb Hemost; 2007 Mar; 33(2):159-64. PubMed ID: 17340464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model.
    Menu E; Asosingh K; Indraccolo S; De Raeve H; Van Riet I; Van Valckenborgh E; Vande Broek I; Fujii N; Tamamura H; Van Camp B; Vanderkerken K
    Haematologica; 2006 May; 91(5):605-12. PubMed ID: 16627256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain.
    Santarelli JG; Udani V; Yung YC; Cheshier S; Wagers A; Brekken RA; Weissman I; Tse V
    Neurosurgery; 2006 Aug; 59(2):374-82; discussion 374-82. PubMed ID: 16883178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells.
    Zernecke A; Schober A; Bot I; von Hundelshausen P; Liehn EA; Möpps B; Mericskay M; Gierschik P; Biessen EA; Weber C
    Circ Res; 2005 Apr; 96(7):784-91. PubMed ID: 15761195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism.
    Carr AN; Howard BW; Yang HT; Eby-Wilkens E; Loos P; Varbanov A; Qu A; DeMuth JP; Davis MG; Proia A; Terjung RL; Peters KG
    Cardiovasc Res; 2006 Mar; 69(4):925-35. PubMed ID: 16409996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells.
    Dar A; Goichberg P; Shinder V; Kalinkovich A; Kollet O; Netzer N; Margalit R; Zsak M; Nagler A; Hardan I; Resnick I; Rot A; Lapidot T
    Nat Immunol; 2005 Oct; 6(10):1038-46. PubMed ID: 16170318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells.
    Guo Y; Hangoc G; Bian H; Pelus LM; Broxmeyer HE
    Stem Cells; 2005 Oct; 23(9):1324-32. PubMed ID: 16210409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.